Results 191 to 200 of about 3,487 (207)

A Canadian case control study investigating demographic and environmental factors associated with MOGAD

Multiple Sclerosis and Related Disorders, 2023
Liesly Lee
exaly  

Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America

Multiple Sclerosis and Related Disorders, 2023
Enrique Gómez-Figueroa, Alejandro Caride, Juan Criniti   +2 more
exaly  

MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders

American Journal of Roentgenology, 2021
Mona Shahriari, David Yousem, Scott Newsome   +2 more
exaly  

Neutrophil to lymphocyte ratio may be a useful marker in distinguishing MOGAD and MS and platelet to lymphocyte ratio associated with MOGAD activity

Multiple Sclerosis and Related Disorders, 2023
exaly  

A Clinical Case of MOGAD

Klinische Monatsblätter für Augenheilkunde
openaire   +2 more sources

Exploring the Molecular Aspects of Glycosylation in MOG Antibody Disease (MOGAD)

Current Protein and Peptide Science, 2022
exaly  

Is there truly no progression in NMOSD and MOGAD?

Multiple Sclerosis and Related Disorders
J, Lechner-Scott, G, Giovannoni, Hawkes, Ch, M, Levy, Yeh, Ea   +4 more
openaire   +2 more sources

Extra-Orbital Manifestations on MOGAD

2020
openaire   +1 more source

Validity of model for predicting risk of relapse in MOGAD

Multiple Sclerosis and Related Disorders
Mulan, Jiang, Philippe Antoine, Bilodeau, Brian, Healy, E Ann, Yeh, Gavin, Giovannoni, Christopher, Hawkes, Jeannette, Lechner-Scott, Michael, Levy   +7 more
openaire   +2 more sources

Utility of the 2023 international MOGAD panel proposed criteria in clinical practice: An institutional cohort

Multiple Sclerosis and Related Disorders
Hesham Abboud, Alessandro Serra
exaly